School of Medicine
Showing 1-100 of 149 Results
-
Alison Callahan
Research Engineer, Med/BMIR
BioAlison Callahan is a research scientist in the Center for Biomedical Informatics and a member of the Shah Lab. Her work involves research and development of informatics methods for the analysis of biomedical and clinical data, to derive insights and inform medical decision making.
Alison completed her PhD in the Department of Biology at Carleton University in Ottawa, Canada. Her doctoral research focused on developing HyQue, a framework for representing and evaluating scientific hypotheses, and applying this framework to discover genes related to aging. She was also a developer for Bio2RDF, an open-source project to build and provide the largest network of Linked Data for the life sciences. -
Yanjia Cao
Postdoctoral Research Fellow, Infectious Diseases
BioI am a postdoctoral research fellow focusing on spatial data modeling and infectious disease epidemiology, specifically typhoid fever, in the Division of Infectious Diseases and Geographic Medicine at Stanford University's School of Medicine under the mentorship of Dr. Jason Andrews.
My research focuses on
(i) applying geospatial techniques to understand spatial burden of typhoid fever
(ii) developing spatial and temporal data models to simulate typhoid fever surveillance -
Robert W. Carlson
Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsClinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.
-
Chris Cartwright, MD
Professor of Medicine (Gastroenterology and Hepatology), Emerita
Current Research and Scholarly InterestsMolecular mechanisms of intestinal cell growth control; function and regulation of the Src family of tyrosine kinases in normal cells, and their deregulation in cancer cells.
-
Jennifer Caswell-Jin
Instructor, Medicine - Oncology
Current Research and Scholarly InterestsMy research is on the translational application of next-generation sequencing technologies to breast cancer care: (1) the value of hereditary cancer genetic panel testing in clinical practice, (2) the mechanisms by which inherited genetic variants lead to breast cancer development, and (3) the analysis of somatic tumor sequencing data to inform understanding of breast tumorigenesis, metastasis, and development of resistance in response to therapeutics.
-
Arianna Celis Luna
Postdoctoral Research Fellow, Infectious Diseases
BioArianna I. Celis Luna is a postdoctoral fellow in the lab of Dr. David Relman. Her research will investigate the role of the GI microbiome on iron absorption during pregnancy. She aims is to elucidate a functional role for the microbiome during this critical time period by combining metatranscriptomic and metametabolomic data from in vivo samples with biochemical data from in vitro samples. She hopes to shed light on how iron-deficiency anemia, still affecting ~50% of pregnant women in developed countries, can be more efficiently treated or prevented.
Arianna received her Ph.D. in Biochemistry from Montana State University in 2018. She worked in the lab of Dr. Jennifer DuBois where her research focused on how, at the molecular level, bacteria build iron into the versatile molecule known as heme and break it apart again. Her work examined how these reactions are critical for both pathogenic species, such as Staphylococcus aureus, and the resident bacteria of the digestive tract.
Arianna’s work encompasses 6 published papers in journals like the Journal of the American Chemical Society, the Journal of Biological Chemistry, and ACS Biochemistry. She has presented her work in several conferences, including Gordon Research Conferences and the ASBMB Annual Meeting, and at Montana State University as part of the Kopriva Science Seminar Series after receiving the Kopriva Graduate Student Fellowship. -
Yashaar Chaichian
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsSystemic lupus erythematosus
CTD-associated interstitial lung disease -
David Chan
Assistant Professor of Medicine (PCOR)
BioDavid Chan, MD, PhD, is an Assistant Professor of Medicine at the Stanford School of Medicine, an investigator at the Department of Veterans Affairs, and a Faculty Research Fellow at the National Bureau of Economic Research. Drawing on labor and organizational economics, he is interested in studying how information is used in health care, how this affects productivity, and implications for design. He is the recipient of the 2014 NIH Director’s High-Risk, High-Reward Early Independence Award to study the optimal balance of information in health information technology for patient care.
Dr. Chan received master’s degrees in policy and economics from the London School of Economics and Oxford University, where he studied as a Marshall scholar. He holds a medical degree from UCLA and a PhD in economics from MIT. He trained in internal medicine at Brigham and Women’s Hospital and was an instructor of medicine at Harvard Medical School, prior to coming to Palo Alto, where he currently is a hospitalist at the Department of Veterans Affairs, Palo Alto. -
Chia Yu Alex Chang
Instructor, Microbiology & Immunology - Baxter Laboratory
Instructor, Medicine - Cardiovascular MedicineCurrent Research and Scholarly InterestsDuchenne muscular dystrophy (DMD) is an X-chromosome-linked genetic disease that is caused by a mutation in the dystrophin gene and affects 1 in every 3500 boys. DMD patients suffer progressive muscle wasting and eventual cardiorespiratory failure that results in an early death in the second or third decade of life. Although extensive research effort has been invested, lack of a good mouse model that mimics the cardiac failure hinders research. We have developed a novel mouse model that exhibit all the symptoms found in DMD patients and our research is aimed at understanding the cardiac failure in DMD for future therapeutic interventions. Our mouse model fully recapitulates the DMD symptoms because we also took into account of the size of human protection DNA on chromosomal ends (telomere) compared to mouse. We would like to study the cause of cardiac failure in our mouse model by 1) determine if telomere shortening is specific to cardiomyocytes, 2) evaluate the level of cellular damage caused by oxidative stress and 3) identify the source of oxidative stress. These experiments will help us to better understand cardiac failure in DMD patients and allow testing of therapeutic interventions.
-
Stephen Chang
Clinical Instructor, Medicine - Cardiovascular Medicine
Postdoctoral Research Fellow, Biochemistry
Ph.D. Student in Biochemistry, admitted Summer 2016BioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease. -
Tara I. Chang
Associate Professor of Medicine (Nephrology) at the Stanford University Medical Center
Current Research and Scholarly InterestsMy research focuses on issues such as blood pressure control, coronary revascularization, and the comparative effectiveness of cardioprotective medications in patients with chronic kidney disease, with the long-term goal of improving cardiovascular outcomes in these high-risk patients.
-
Jonathan H. Chen, MD, PhD
Assistant Professor of Medicine (Biomedical Informatics) at the Stanford University Medical Center
Current Research and Scholarly InterestsInformatics solutions ares the only credible approach to systematically address challenges of escalating complexity in healthcare. Tapping into real-world clinical data streams like electronic medical records will reveal the community's latent knowledge in a reproducible form. Delivering this back as clinical decision support will uniquely close the loop on a continuously learning health system.
-
Julie Chen
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioJulie Chen, MD, is a clinical assistant professor in endocrinology at Stanford University. Dr. Chen graduated from Albert Einstein College of Medicine. She then completed her internal medicine residency at the University of California, San Diego and endocrinology fellowship at Stanford University Medical Center. She is double board certified in internal medicine and endocrinology.
Dr. Chen practices general endocrinology but her clinical interest include thyroid disease/thyroid cancer, pituitary disease, and disorders of the bone. She also has a special interest in medical education and has developed online teaching resources for the endocrine fellowship program. -
Xingxing Shelley Cheng
Clinical Assistant Professor, Medicine - Nephrology
Current Research and Scholarly InterestsDr. Xingxing Cheng's expertise is in applying the tools of decision science to clinical practice and policy analysis. Her current research is in the following areas:
1) pre-kidney transplant cardiovascular screening;
2) change in physical function with and without kidney transplant;
3) ethics of kidney allocation in multi-organ transplantation. -
Glenn M. Chertow
Professor of Medicine (Nephrology) and, by courtesy, of Health Research and Policy (Epidemiology)
Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease
-
Ramsey Cheung
Professor of Medicine (Gastroenterology and Hepatology) at the Palo Alto Veterans Affairs Health Care System
Current Research and Scholarly InterestsDr. Cheung's research interests focus on liver diseases, with emphasis on viral hepatitis. His past research include investigating the mechanism of viral neutralization of hepatitis B virus at the molecular level and immune response to hepatitis C virus. Dr. Cheung is studing various aspects of hepatitis C, both clinical and translational research.
-
Mildred Cho, PhD
Professor (Research) of Pediatrics (Center for Biomedical Ethics) and of Medicine (General Medical Disciplines)
Current Research and Scholarly InterestsDr. Cho's major areas of interest include: ethical and social issues in genetic research, including those arising from gene therapy and editing, synthetic biology, microbiome research, the use of artificial intelligence to analyze genomic and medical data, the effects of gene patenting on clinical genetic testing and research, and the impacts of academic-industry ties on biomedical research.
-
Curtis R. Chong, MD, PhD, MPhil, FACP
Clinical Assistant Professor, Medicine - Oncology
BioDr. Chong was recruited to Stanford from the Memorial Sloan Kettering (MSK) Cancer Center, where he led MSK's launch of the early drug development and immunotherapy clinical trials program in New Jersey. At MSK, Dr. Chong was a member of the gastrointestinal oncology service and was one of two MSK physicians in New Jersey who specialized in treating melanoma. Prior to joining MSK, Dr. Chong was a member of the thoracic oncology service at the Dana-Farber Cancer Institute and an attending physician at the Massachusetts General Hospital and Brigham and Women's Hospital, all ailiates of Harvard Medical School.
Dr. Chong completed his categorical residency in internal medicine at the Massachusetts General Hospital/Harvard Medical School, his oncology fellowship at the Dana-Farber Cancer Institute, and is board-certified in internal medicine and medical oncology. He has received research support from the American Society of Clinical Oncology (Young Investigator Award), Uniting Against Lung Cancer, and the American Cancer Society. Dr. Chong has been published in the New England Journal of Medicine, Nature, Nature Medicine, Nature Chemical Biology, JAMA Oncology, and his research on drug discovery has been featured in the New York Times and Popular Science.
Born and raised in Honolulu where he attended public schools, Dr. Chong sang in the Honolulu Boy Choir, and was the 1993 Honolulu Star Bulletin Newspaper Boy of the Year. He received his A.B. in biochemical sciences from Harvard University magna cum laude followed by an M.Phil. in Chemistry with Sir Alan Fersht at the University of Cambridge (Emmanuel College). He then received his MD and PhD in pharmacology from The Johns Hopkins University School of Medicine.
An intrepid traveler and avid long-distance runner, Dr. Chong has visited 54 countries and completed 126 marathons in all 50 states, 18 countries, and 6 on continents. -
Alvina Dor-Yan Chu
Adjunct Clinical Instructor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsOur laboratory seeks to understand how cells repair DNA damage. We currently focus on how non-homologous end joining proteins assemble on DNA ends to juxtapose them for repair of DNA double-strand breaks.
We are collaborating on a point-of-care device to measure ammonia from a drop of blood. The device will facilitate diagnosis and management of urea cycle defects, liver disease, and chemobrain due to elevated ammonia. -
Weihan Chu
Clinical Assistant Professor, Medicine
BioWeihan Chu, M.D., is a clinical assistant professor at Stanford School of Medicine. He completed his M.D. degree at Case Western Reserve University and his Internship and Residency at Stanford Hospital. He has been working at Stanford Health Care ValleyCare Hospital as an academic hospitalist since 2015.
He serves as the Medical Informatics Director at SHC ValleyCare hospital and spends his time focused on leveraging technology to improve patient care. At SHC ValleyCare, he was the physician champion for the hospital's transition to electronic medical records and currently serves as the chair of the Physician IT Advisory Committee and the Clinical Decision Support Committee.
He interested in hospital based quality improvement projects. His past projects include the sepsis initiative at Stanford hospital and minimizing delay in obtaining outside hospital records.
In his spare time, he enjoys hiking, scuba diving, photography, and keeping up to date with the latest tech gadgets. -
Katrin Chua
Associate Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
